A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™ CAT) in eliminating fleas in client-owned cats in the USA

BACKGROUND: Studies show that the novel isoxazoline, lotilaner (Credelio™ CAT; Elanco Animal Health), which is administered orally to cats, provides rapid and sustained flea kill for least 1 month following administration with a wide safety margin. A clinical trial was undertaken to confirm its effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chappell, Kimberly, Paarlberg, Tandy, Seewald, Wolfgang, Karadzovska, Daniela, Nanchen, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923547/
https://www.ncbi.nlm.nih.gov/pubmed/33648556
http://dx.doi.org/10.1186/s13071-021-04617-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923547/
https://www.ncbi.nlm.nih.gov/pubmed/33648556
http://dx.doi.org/10.1186/s13071-021-04617-5

Ejemplares similares